Developmental Care for Congenital Heart Defects

sb
KS
Overseen ByKatrina Severtson, BS
Age: < 18
Sex: Any
Trial Phase: Academic
Sponsor: Boston Children's Hospital
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests a new approach to care for newborns with congenital heart defects (CHD) to determine if it can improve their development and health outcomes. The focus is on using individualized developmental care (IDC) in the hospital to reduce stress from treatments and help both infants and their parents cope better. In this trial, one group of infants will receive this special care, known as NIDCAP Developmental Care, while another group will receive standard hospital care. Good candidates for this study are newborns at Boston Children's Hospital with complex CHD requiring early heart surgery, who are free from other major health issues and have access to a phone or the internet. As an unphased trial, this study offers a unique opportunity to contribute to innovative care strategies for newborns with CHD.

Will I have to stop taking my current medications?

The trial information does not specify whether participants need to stop taking their current medications.

What prior data suggests that this developmental care intervention is safe for infants with congenital heart disease?

Research has shown that the Newborn Individualized Developmental Care and Assessment Program (NIDCAP) is safe and well-tolerated. Studies indicate that NIDCAP improves outcomes for premature babies by supporting brain development, enhancing thinking skills, and improving behavior without causing harm. These findings suggest that NIDCAP is safe for infants.

In this trial, researchers are testing NIDCAP for babies with congenital heart defects. Although this application is new for these patients, the positive safety record in other infant groups is encouraging. NIDCAP aims to reduce stress and create a calming hospital environment. This approach is designed to support healthy development, making it a low-risk option.12345

Why are researchers excited about this trial?

Researchers are excited about the NIDCAP developmental care for congenital heart defects because it offers a unique approach to supporting infants with these conditions. Unlike standard medical treatments that focus primarily on surgical or pharmaceutical interventions, NIDCAP emphasizes individualized care tailored to each infant's developmental needs. This approach aims to create a nurturing environment that supports brain development and enhances long-term outcomes. By focusing on personalized, sensitive care, NIDCAP could potentially improve cognitive and emotional development in ways that traditional medical treatments do not address.

What evidence suggests that this developmental care is effective for congenital heart defects?

Research shows that the Newborn Individualized Developmental Care and Assessment Program (NIDCAP) can greatly help babies in intensive care. Studies have found that babies receiving NIDCAP often experience better health outcomes, such as reduced time on breathing machines and easier weight gain. Evidence also suggests these babies may spend less time in the hospital. While most research has focused on premature babies, the positive results indicate potential benefits for babies with congenital heart defects (CHD) as well. In this trial, some participants will receive NIDCAP developmental care, while others will receive standard care. By reducing stress and supporting growth, NIDCAP may improve both the health and development of these babies over time.13678

Who Is on the Research Team?

SB

Samantha Butler, PhD

Principal Investigator

Boston Children's Hospital

Are You a Good Fit for This Trial?

This trial is for newborns with complex congenital heart disease admitted to Boston Children's Hospital within 3 days of birth, needing open-heart surgery within two weeks. Eligible infants must be full-term, have no prior cardiac surgeries or severe associated anomalies, and not exposed to maternal substances. Mothers should be aged 20-45 years without known chromosomal abnormalities.

Inclusion Criteria

I am a mother aged between 20 and 45 years.
You are more than 37 weeks pregnant.
You do not have multiple birth defects or conditions like CHARGE syndrome.
See 8 more

Exclusion Criteria

I have had a cardiac arrest, CPR, ECMO, or VAD before joining this study.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

Infants receive Individualized Developmental Care (IDC) following the NIDCAP model in the Cardiac Intensive Care Unit (CICU) and Acute Cardiology Care Unit (ACCU).

up to 2 months
Continuous care during hospital stay

Follow-up

Participants are monitored for developmental outcomes and parent engagement after discharge.

3 months

What Are the Treatments Tested in This Trial?

Interventions

  • NIDCAP Developmental Care
Trial Overview The study tests a developmental care intervention (IDC) designed to improve outcomes for hospitalized newborns with congenital heart disease by reducing stress and supporting development in the intensive care setting. It aims to show benefits such as shorter hospital stays, better feeding/growth, enhanced development, and improved parental coping.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
Group II: standard of careActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Boston Children's Hospital

Lead Sponsor

Trials
801
Recruited
5,584,000+

Published Research Related to This Trial

The Neonatal Individualized Developmental Care and Assessment Program (NIDCAP) helps improve the care of premature newborns by using behavioral observations to tailor caregiving and environmental conditions, which supports their development.
Implementing NIDCAP in neonatal intensive care units has been associated with reduced need for ventilation and artificial feeding, shorter hospital stays, and enhanced neurobehavioral maturation in infants.
[Implementation of an individualized program of sustained development in neonatal intensive care: why, how?].Sizun, J., Ratynski, N., Mambrini, C.[2019]
In a study comparing Newborn Individualized Developmental Care and Assessment Program (NIDCAP) to conventional care in a NICU, NIDCAP infants had a significantly lower risk of severe cerebral damage, with an odds ratio of 0.12, suggesting potential neuroprotective benefits despite other clinical outcomes being similar.
However, NIDCAP infants experienced a higher incidence of pneumonia due to nosocomial infections (9 vs. 3), indicating a need for careful monitoring and further research to balance the benefits and risks of this care approach.
Individualized developmental care in a Dutch NICU: short-term clinical outcome.Wielenga, JM., Smit, BJ., Merkus, MP., et al.[2019]
The implementation of the Newborn Individualized Developmental Care and Assessment Program (NIDCAP) was positively perceived by NICU staff, with nurses reporting significantly higher satisfaction and perceived benefits compared to doctors, indicating a strong acceptance of the program among healthcare providers.
Staff believed that NIDCAP improved infant care and well-being, as well as enhanced relationships with parents, although they noted that working conditions still posed challenges, highlighting areas for future improvement.
Implementing NIDCAP training in a low-middle-income country: Comparing nurses and physicians' attitudes.Charafeddine, L., Masri, S., Sharafeddin, SF., et al.[2021]

Citations

Comprehensive Care for Preterm Infants - PubMed Central - NIHThe Newborn Individualized Developmental Care and Assessment Program (NIDCAP) aims to prevent the iatrogenic sequelae of intensive care and to maintain the ...
Newborn Individualized Developmental Care and ...The mortality among infants born preterm has decreased dramatically during the last decade in developed countries.
NCT05885113The proposed study includes a newborn developmental intervention to improve neurodevelopmental (ND) and medical outcomes for infants with congenital heart ...
The newborn individualised developmental care and ...Evidence shows NIDCAP significantly improves medical outcomes, with less time on the ventilator, improved weight gain, decreased length of stay, ...
Program Guide Newborn Individualized Developmental ...Newborn Individualized Developmental Care and Assessment Program (NIDCAP). An Education and Training Program for Health Care Professionals.
Individualized Developmental Care to Improve the Lives of ...Despite the research and publications on the positive outcomes for NIDCAP and the increasing availability of NIDCAP training, it is not ...
Developmental Care for Hospitalized Infants With Complex ...Developmental disorders, disabilities, and delays are a common outcome for individuals with complex congenital heart disease, yet targeting early factors ...
Developmental ObserverThe purpose of this project is to disseminate the most current developmental practices to rehabilitation professionals working in the critical care environ-.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security